Spectrum Pharmaceuticals, Inc. logo

Spectrum Pharmaceuticals, Inc. Share Price (NASDAQ: SPPI)

▲

-1.03

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 31 Jul 2023

Check the interactive Spectrum Pharmaceuticals, Inc. Stock chart to analyse performance

Spectrum Pharmaceuticals, Inc. Key Stats

Check Spectrum Pharmaceuticals, Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.03
Open
$1.02
Market Capitalization
$200.8M
Today's Volume
$5.9M
Revenue TTM
$25.7M
EBITDA
$-63.3M
Earnings Per Share (EPS)
$-0.37
Dividend Yield
0.0%
Profit Margin
-252.5%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-165.02%

Global Institutional Holdings in Spectrum Pharmaceuticals, Inc.

  • Name

    Holdings %

  • Armistice Capital, LLC

    8.14%

  • Vanguard Group Inc

    4.28%

  • Acadian Asset Management LLC

    1.81%

  • BlackRock Inc

    1.68%

  • Geode Capital Management, LLC

    0.86%

  • Morgan Stanley - Brokerage Accounts

    0.56%

Analyst Recommendation on Spectrum Pharmaceuticals, Inc. Stock

Rating
Trend

Hold

    0%Buy

    70%Hold

    30%Sell

Based on 10 Wall street analysts offering stock ratings for Spectrum Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)

About Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products. It offers ROLVEDON(Eflapegrastim), a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. The company develops Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and license agreement with Therapyx, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Boston, Massachusetts.
Organization
Spectrum Pharmaceuticals, Inc.
Employees
86
CEO
Mr. Thomas J. Riga
Industry
Health Technology

Important FAQs about investing in SPPI Stock from India :

What is Spectrum Pharmaceuticals, Inc. share price today?

Spectrum Pharmaceuticals, Inc. share price today is as on at the close of the market. Spectrum Pharmaceuticals, Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Spectrum Pharmaceuticals, Inc. share?

Spectrum Pharmaceuticals, Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Spectrum Pharmaceuticals, Inc. stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Spectrum Pharmaceuticals, Inc. Stock (SPPI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Spectrum Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Spectrum Pharmaceuticals, Inc. Shares .

What is the minimum amount required to buy Spectrum Pharmaceuticals, Inc. Stock (SPPI) from India?

Indian investors can start investing in Spectrum Pharmaceuticals, Inc. (SPPI) shares with as little as ₹88.059 or $1 (as of October 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹880.59 in Spectrum Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on October 16, 2025). Learn more about fractional shares .

What are the returns that Spectrum Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?

Spectrum Pharmaceuticals, Inc. stock has given 0.0% share price returns and 19.91% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?